Novartis signs deal with Britain’s NHS for new cholesterol drug Leqvio
(Reuters) – Novartis AG said on Wednesday it had agreed a deal with Britain’s healthcare...
1st September, 2021
(Reuters) – Novartis AG said on Wednesday it had agreed a deal with Britain’s healthcare...
1st September, 2021
By Rocky Swift TOKYO (Reuters) -Japan suspended the use of 1.63 million doses of Moderna Inc’s...
26th August, 2021
By Julie Steenhuysen CHICAGO (Reuters) – A booster dose of Johnson & Johnson’s COVID...
25th August, 2021
By Shashank Nayar (Reuters) – London’s FTSE 100 rose slightly on Wednesday, helped by ga...
25th August, 2021
By Susan Heavey and Carl O’Donnell WASHINGTON (Reuters) – The United States could get CO...
25th August, 2021
By Maayan Lubell JERUSALEM (Reuters) -Less than a month into a COVID-19 vaccine booster drive, Israe...
24th August, 2021
A leading name in the healthcare sector, MAKO Medical Laboratories is an innovative and forward-thin...
20th August, 2021
(Reuters) – The mass rollout of COVID-19 booster vaccines in Britain to residents over 50 this...
20th August, 2021
By Carl O’Donnell and Manojna Maddipatla (Reuters) – Johnson & Johnson on Thursday a...
20th August, 2021
By Siddharth Cavale (Reuters) -Cigarette maker Philip Morris International (PMI) said on Wednesday s...
19th August, 2021
TEL AVIV (Reuters) – A third dose of Pfizer/BioNTech’s COVID-19 vaccine was found to be...
18th August, 2021
By Carl O’Donnell and Ahmed Aboulenein (Reuters) -The U.S. government said on Wednesday it pla...
18th August, 2021